Eisai
4523.T
#2172
Rank
NZ$14.73 B
Marketcap
NZ$52.22
Share price
0.68%
Change (1 day)
4.24%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: NZ$0.90 Billion

According to Eisai's latest financial reports the company's current earnings are NZ$5.06 Billion. In 2023 the company made an earning of NZ$0.90 Billion, an increase over its 2022 earnings that were of -NZ$39.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023NZ$0.90 B-2404.04%
2022-NZ$39.37 Million-103.6%
2021NZ$1.09 B-39.81%
2020NZ$1.81 B7.44%
2019NZ$1.69 B17.22%
2018NZ$1.44 B86.16%
2017NZ$0.77 B-23.52%
2016NZ$1.01 B26.97%
2015NZ$0.79 B22.3%
2014NZ$0.65 B-46.07%
2013NZ$1.21 B-21.85%
2012NZ$1.54 B-20.59%
2011NZ$1.95 B-8.91%
2010NZ$2.14 B19.21%
2009NZ$1.79 B